| Primary |
| Product Used For Unknown Indication |
28.8% |
| Benign Prostatic Hyperplasia |
22.5% |
| Drug Use For Unknown Indication |
13.5% |
| Hypertension |
6.0% |
| Dysuria |
5.4% |
| Bladder Obstruction |
4.1% |
| Pollakiuria |
2.9% |
| Prostatomegaly |
2.6% |
| Respiratory Tract Infection |
2.6% |
| Prostate Cancer |
1.7% |
| Diabetes Mellitus |
1.5% |
| Urinary Retention |
1.5% |
| Gastritis |
1.1% |
| Constipation |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Renal Transplant |
0.9% |
| Insomnia |
0.8% |
| Nasal Congestion |
0.8% |
| Prostatic Disorder |
0.8% |
|
| Retrograde Ejaculation |
14.8% |
| Drug Ineffective |
10.9% |
| Loss Of Consciousness |
9.4% |
| Dizziness |
8.2% |
| Death |
7.8% |
| Nasal Congestion |
7.4% |
| Ejaculation Failure |
4.7% |
| Liver Disorder |
4.7% |
| Syncope |
4.7% |
| Diarrhoea |
4.3% |
| Orthostatic Hypotension |
2.7% |
| Swelling Face |
2.7% |
| Urinary Retention |
2.7% |
| Fatigue |
2.3% |
| Hepatic Function Abnormal |
2.3% |
| Platelet Count Decreased |
2.3% |
| Condition Aggravated |
2.0% |
| Constipation |
2.0% |
| Headache |
2.0% |
| Hypotension |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
36.4% |
| Benign Prostatic Hyperplasia |
17.3% |
| Drug Use For Unknown Indication |
13.2% |
| Dysuria |
4.4% |
| Hypertension |
4.1% |
| Bladder Obstruction |
3.6% |
| Pollakiuria |
2.7% |
| Urinary Incontinence |
2.5% |
| Prostate Cancer |
2.2% |
| Constipation |
1.6% |
| Hypertonic Bladder |
1.6% |
| Micturition Urgency |
1.6% |
| Prostatomegaly |
1.4% |
| Blood Pressure |
1.1% |
| Musculoskeletal Pain |
1.1% |
| Oropharyngeal Pain |
1.1% |
| Prostatic Disorder |
1.1% |
| Sinus Congestion |
1.1% |
| Upper-airway Cough Syndrome |
1.1% |
| Arthritis |
0.8% |
|
| Loss Of Consciousness |
8.5% |
| Vertigo |
8.5% |
| Diarrhoea |
6.4% |
| Nasal Congestion |
6.4% |
| Pruritus |
6.4% |
| Respiratory Failure |
6.4% |
| Unevaluable Event |
6.4% |
| Aortic Aneurysm |
4.3% |
| Death |
4.3% |
| Dizziness |
4.3% |
| Eosinophilic Pneumonia Acute |
4.3% |
| Fatigue |
4.3% |
| Liver Disorder |
4.3% |
| Nausea |
4.3% |
| Prostate Cancer |
4.3% |
| Pruritus Generalised |
4.3% |
| Swelling Face |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Abdominal Discomfort |
2.1% |
| Alanine Aminotransferase Increased |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
56.6% |
| Hypertension |
5.4% |
| Colorectal Cancer Metastatic |
3.6% |
| Prostatomegaly |
3.4% |
| Pain |
3.1% |
| Benign Prostatic Hyperplasia |
2.9% |
| Blood Cholesterol Increased |
2.7% |
| Depression |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Atrial Fibrillation |
2.1% |
| Diabetes Mellitus |
2.1% |
| Prostatic Disorder |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Anxiety |
1.8% |
| Prostate Cancer |
1.8% |
| Multiple Sclerosis |
1.7% |
| Blood Cholesterol |
1.3% |
| Constipation |
1.3% |
| Osteoporosis |
1.0% |
| Arrhythmia |
0.8% |
|
| Death |
10.3% |
| Vomiting |
8.8% |
| Drug Ineffective |
7.4% |
| Orthostatic Hypotension |
7.4% |
| Weight Increased |
7.4% |
| Blood Testosterone Decreased |
5.9% |
| Hypertension |
5.9% |
| Herpes Zoster |
4.4% |
| Nausea |
4.4% |
| Pruritus |
4.4% |
| Respiratory Failure |
4.4% |
| Swollen Tongue |
4.4% |
| Syncope |
4.4% |
| Agitation |
2.9% |
| Bladder Disorder |
2.9% |
| Blood Glucose Increased |
2.9% |
| Blood Pressure Increased |
2.9% |
| Constipation |
2.9% |
| Ejaculation Failure |
2.9% |
| Fatigue |
2.9% |
|
| Interacting |
| Lyme Disease |
50.0% |
| Benign Prostatic Hyperplasia |
25.0% |
| Arthralgia |
12.5% |
| Urine Flow Decreased |
12.5% |
|
| Drug Interaction |
66.7% |
| Product Quality Issue |
33.3% |
|
